News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteomika and Auguron Partnered up for DNA-Based Protein Chips in Biomarker Discovery



6/3/2008 8:27:19 AM

ZAMUDIO, Spain--(BUSINESS WIRE)--Proteomika, a subsidiary of Personalised Medicine leader Progenika Biopharma SA, announced today an option agreement with Auguron Biosciences, Inc, giving them rights to exclusive access in two autoimmune disease areas to use Auguron’s Nucleic Acid Programmable Protein Array (NAPPA) technology.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES